262 related articles for article (PubMed ID: 25901944)
21. Structural and functional characterization of human and murine C5a anaphylatoxins.
Schatz-Jakobsen JA; Yatime L; Larsen C; Petersen SV; Klos A; Andersen GR
Acta Crystallogr D Biol Crystallogr; 2014 Jun; 70(Pt 6):1704-17. PubMed ID: 24914981
[TBL] [Abstract][Full Text] [Related]
22. C5a and C5a(desArg) enhance the susceptibility of monocyte-derived macrophages to HIV infection.
Kacani L; Bánki Z; Zwirner J; Schennach H; Bajtay Z; Erdei A; Stoiber H; Dierich MP
J Immunol; 2001 Mar; 166(5):3410-5. PubMed ID: 11207298
[TBL] [Abstract][Full Text] [Related]
23. Inactivation of human anaphylatoxin C5a and C5a des-Arg through cleavage by the plasminogen activator activity of a human fibrosarcoma cell line.
Higazi A al-R ; Barghouti II
J Biol Chem; 1994 Oct; 269(41):25529-33. PubMed ID: 7929254
[TBL] [Abstract][Full Text] [Related]
24. Receptors for complement C5a. The importance of C5aR and the enigmatic role of C5L2.
Lee H; Whitfeld PL; Mackay CR
Immunol Cell Biol; 2008 Feb; 86(2):153-60. PubMed ID: 18227853
[TBL] [Abstract][Full Text] [Related]
25. Chimeric receptors of the human C3a receptor and C5a receptor (CD88).
Crass T; Ames RS; Sarau HM; Tornetta MA; Foley JJ; Köhl J; Klos A; Bautsch W
J Biol Chem; 1999 Mar; 274(13):8367-70. PubMed ID: 10085065
[TBL] [Abstract][Full Text] [Related]
26. Intravitreal inhibition of complement C5a reduces choroidal neovascularization in mice.
Brockmann C; Brockmann T; Dege S; Busch C; Kociok N; Vater A; Klussmann S; Strauß O; Joussen AM
Graefes Arch Clin Exp Ophthalmol; 2015 Oct; 253(10):1695-704. PubMed ID: 25981118
[TBL] [Abstract][Full Text] [Related]
27. C5a receptor-dependent cell activation by physiological concentrations of desarginated C5a: insights from a novel label-free cellular assay.
Reis ES; Chen H; Sfyroera G; Monk PN; Köhl J; Ricklin D; Lambris JD
J Immunol; 2012 Nov; 189(10):4797-805. PubMed ID: 23041570
[TBL] [Abstract][Full Text] [Related]
28. Requirements for C5a receptor-mediated IL-4 and IL-13 production and leukotriene C4 generation in human basophils.
Eglite S; Plüss K; Dahinden CA
J Immunol; 2000 Aug; 165(4):2183-9. PubMed ID: 10925305
[TBL] [Abstract][Full Text] [Related]
29. The Model Structures of the Complement Component 5a Receptor (C5aR) Bound to the Native and Engineered
Sahoo AR; Mishra R; Rana S
Sci Rep; 2018 Feb; 8(1):2955. PubMed ID: 29440703
[TBL] [Abstract][Full Text] [Related]
30. An anti-inflammatory function for the complement anaphylatoxin C5a-binding protein, C5L2.
Gerard NP; Lu B; Liu P; Craig S; Fujiwara Y; Okinaga S; Gerard C
J Biol Chem; 2005 Dec; 280(48):39677-80. PubMed ID: 16204243
[TBL] [Abstract][Full Text] [Related]
31. Role of C5a-C5aR axis in the development of atherosclerosis.
An G; Ren G; An F; Zhang C
Sci China Life Sci; 2014 Aug; 57(8):790-4. PubMed ID: 25104451
[TBL] [Abstract][Full Text] [Related]
32. Allosterism in human complement component 5a ((h)C5a): a damper of C5a receptor (C5aR) signaling.
Rana S; Sahoo AR; Majhi BK
J Biomol Struct Dyn; 2016 Jun; 34(6):1201-13. PubMed ID: 26212097
[TBL] [Abstract][Full Text] [Related]
33. Contribution of anaphylatoxin C5a to late airway responses after repeated exposure of antigen to allergic rats.
Abe M; Shibata K; Akatsu H; Shimizu N; Sakata N; Katsuragi T; Okada H
J Immunol; 2001 Oct; 167(8):4651-60. PubMed ID: 11591795
[TBL] [Abstract][Full Text] [Related]
34. The anaphylatoxin C5a: Structure, function, signaling, physiology, disease, and therapeutics.
Ghosh M; Rana S
Int Immunopharmacol; 2023 May; 118():110081. PubMed ID: 36989901
[TBL] [Abstract][Full Text] [Related]
35. Characterization of rat C5a anaphylatoxin receptor (C5aR): cloning of rat C5aR cDNA and study of C5aR expression by rat astrocytes.
Sayah S; Patte C; Gasque P; Chan P; Ischenko A; Vaudry H; Fontaine M
Brain Res Mol Brain Res; 1997 Sep; 48(2):215-22. PubMed ID: 9332718
[TBL] [Abstract][Full Text] [Related]
36. Identification of classical anaphylatoxin as the des-Arg form of the C5a molecule: evidence of a modulator role for the oligosaccharide unit in human des-Arg74-C5a.
Gerard C; Hugli TE
Proc Natl Acad Sci U S A; 1981 Mar; 78(3):1833-7. PubMed ID: 6940191
[TBL] [Abstract][Full Text] [Related]
37. The evolutionary analysis of complement component C5 and the gene co-expression network and putative interaction between C5a and C5a anaphylatoxin receptor (C5AR/CD88) in human and two Cyprinid fish.
Li L; Yang W; Shen Y; Xu X; Li J
Dev Comp Immunol; 2021 Mar; 116():103958. PubMed ID: 33290783
[TBL] [Abstract][Full Text] [Related]
38. Site-specific mutagenesis of residues in the human C5a anaphylatoxin which are involved in possible interaction with the C5a receptor.
Bubeck P; Grötzinger J; Winkler M; Köhl J; Wollmer A; Klos A; Bautsch W
Eur J Biochem; 1994 Feb; 219(3):897-904. PubMed ID: 8112341
[TBL] [Abstract][Full Text] [Related]
39. Differential expression of the C5a receptor on the main cell types of rat liver as demonstrated with a novel monoclonal antibody and by C5a anaphylatoxin-induced Ca2+ release.
Schlaf G; Schieferdecker HL; Rothermel E; Jungermann K; Götze O
Lab Invest; 1999 Oct; 79(10):1287-97. PubMed ID: 10532591
[TBL] [Abstract][Full Text] [Related]
40. Anaphylatoxin receptor promiscuity for commonly used complement C5a peptide agonists.
Li XX; Clark RJ; Woodruff TM
Int Immunopharmacol; 2021 Nov; 100():108074. PubMed ID: 34454293
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
